Why prioritised access matters
Public AOD systems in Australia explicitly prioritise pregnant women — recognising that the foetus has a finite developmental window, that AOD-related harm in pregnancy compounds rapidly, and that pregnancy is also a high-motivation period when treatment uptake and outcomes are particularly good. In practice this means same-week assessment is standard, multi-disciplinary teams (obstetrician, addiction medicine, psychiatry, social work) are routinely available, and child protection involvement is managed as a treatment variable rather than a barrier.
Critically: do not stop using alcohol or opioids cold-turkey if you are pregnant and dependent. Withdrawal during pregnancy can trigger preterm labour and foetal distress; supervised tapering or maintenance is safer for both you and the foetus. The first call is your obstetrician, GP, or a state alcohol and drug line — they will route you to specialist care immediately.
Specialist services across Australia
- NSW — CAMS (Chemical Use in Pregnancy and Parenting Service): Statewide service, integrated antenatal and AOD care. Royal Hospital for Women, Westmead, John Hunter, Wollongong, and other tertiary centres run CAMS clinics.
- VIC — Women's Alcohol and Drug Service (WADS): Royal Women's Hospital, Mercy Hospital for Women. Substance-using-pregnancy specialists.
- QLD — T3 (Drug and Alcohol Services in Pregnancy): Royal Brisbane Women's, Mater, integrated with maternity services.
- WA — Subi Centre / King Edward Memorial Hospital: WA's specialist substance-using-pregnancy service.
- SA — DASSA Pregnancy and Parenting Service: Adelaide-based, integrated with WCH antenatal.
- ACT — Centenary Hospital for Women and Children: Integrated AOD-and-pregnancy clinic.
- TAS / NT: Smaller services co-located with major maternity hospitals.
Medication-assisted treatment in pregnancy
Opioids: Methadone and buprenorphine are both considered safe and are first-line. Switching to abstinence in pregnancy is more dangerous than maintenance — relapse risk is high and overdose during relapse is the leading cause of maternal mortality in opioid-dependent pregnancies. Babies born to women on methadone or buprenorphine may experience neonatal abstinence syndrome (NAS), which is well-managed in any major Australian maternity unit.
Alcohol: Tapered withdrawal under medical supervision in the first or early second trimester is the standard approach. Naltrexone and acamprosate are both used in selected cases. Disulfiram is contraindicated in pregnancy.
Benzodiazepines: Tapering only, never abrupt cessation. Specialist input essential.
Stimulants (ice, cocaine, amphetamines): No specific medication; supportive care, sleep, nutrition, and psychological support are the core interventions.
Cannabis: Cessation is recommended; no specific medication. Most women stop spontaneously upon learning they are pregnant.
Tobacco / nicotine: NRT (patches, gum) is preferred over continued smoking in pregnancy. Varenicline and bupropion are generally avoided.
Child protection and confidentiality
AOD treatment during pregnancy can intersect with child protection — different in each state, but generally treatment-focused services have stronger relationships with statutory authorities than punitive ones. A documented record of engaging with treatment is universally protective; non-engagement with offered care is a much bigger child-safety concern than substance use itself.
Specialist services are bound by privacy law and only mandatory-report on imminent danger. They do not call child protection because a pregnant woman is using substances; they call when there is risk of immediate harm and treatment is not progressing. The CAMS, WADS, and T3 services in particular have decades of experience navigating this — their interest is in your treatment success, not statutory escalation.
Frequently asked questions
Can I detox safely while pregnant?
Yes, under specialist supervision. Cold-turkey withdrawal from alcohol or opioids during pregnancy can cause foetal distress, preterm labour, or miscarriage — far more dangerous than continued substance use or medication-assisted treatment. The right path is medical detox in a hospital with maternity capability, or supervised tapering with regular obstetric monitoring.
Will my baby have NAS (neonatal abstinence syndrome)?
If you are on methadone or buprenorphine in pregnancy, NAS is common but well-managed in any major Australian maternity unit. Treatment is supportive (swaddling, low stimulation) and where needed, short-term medication. Most babies are discharged home within 5–10 days. Ongoing risks to the baby are very low and are not predictive of long-term developmental issues.
Will child protection be involved?
Specialist services are bound by privacy law and only mandatory-report on imminent danger. Engagement with treatment is universally protective — child protection is concerned when treatment is not happening, not because substance use exists. CAMS, WADS, T3 and equivalent services have established protocols and relationships that prioritise treatment outcomes.
Can my partner be involved?
Yes. Family-inclusive treatment in pregnancy AOD care produces strong outcomes for both the woman and the developing parent-infant relationship. Most specialist services explicitly include partners in counselling, antenatal classes, and family programs.